Parallel Advisors’s Transmedics TMDX Stock Holding History

Parallel Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.7K	Buy	409 +129	+46%	+$16.8K	﹤0.01%	2111
2025 Q4	$34.1K	Buy	280 +83	+42%	+$10.4K	﹤0.01%	2046
2025 Q3	$22.1K	Sell	197 -7	-3%	-$819	﹤0.01%	2195
2025 Q2	$27.3K	Sell	204 -8	-4%	-$878	﹤0.01%	2041
2025 Q1	$14.3K	Buy	212 +14	+7%	+$963	﹤0.01%	2293
2024 Q4	$12.3K	Sell	198 -106	-35%	-$9.87K	﹤0.01%	2345
2024 Q3	$47.7K	Buy	304 +12	+4%	+$1.85K	﹤0.01%	1657
2024 Q2	$44K	Buy	292 +132	+83%	+$15.8K	﹤0.01%	1594
2024 Q1	$11.8K	Hold	160	–	–	﹤0.01%	2235
2023 Q4	$12.6K	Hold	160	–	–	﹤0.01%	2194
2023 Q3	$8.76K	Hold	160	–	–	﹤0.01%	2270
2023 Q2	$13.4K	Sell	160 -19	-11%	-$1.45K	﹤0.01%	2049
2023 Q1	$13.6K	Sell	179 -50	-22%	-$3.46K	﹤0.01%	2010
2022 Q4	$14.1K	Buy	229 +69	+43%	+$3.67K	﹤0.01%	1878
2022 Q3	$7K	Buy	+160	New	+$6.96K	﹤0.01%	2167
2022 Q1	–	Sell	-12	Closed	–	–	3273
2021 Q4	$0	Buy	+12	New	+$301	﹤0.01%	3293

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parallel Advisors's TMDX Position: Q1 2026 in Review

Parallel Advisors increased its Transmedics (TMDX) stake by 46% in Q1 2026, buying an estimated $16.8K and bringing the position to 409 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2111.

Parallel Advisors first reported a position in TMDX in Q4 2021 and has held it in 16 quarters since. The position peaked at $47.7K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Parallel Advisors held 409 shares of Transmedics worth $40.7K as of Q1 2026.
Parallel Advisors bought 129 Transmedics shares in Q1 2026, an estimated $16.8K.
Transmedics made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2111 holding.
Parallel Advisors first reported a position in Transmedics in Q4 2021 and has held it in 16 quarters since.
Parallel Advisors's Transmedics position peaked at $47.7K in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.